カテゴリ： 世界, 医療/バイオ, QYResearch

フィラリア症治療の世界市場2023年：スプレー薬、服用薬、その他

■ 英語タイトル：Global Heartworm Disease Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8782）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8782
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[フィラリア症治療の世界市場2023年：スプレー薬、服用薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はフィラリア症治療のグローバル市場について調査・分析し、世界のフィラリア症治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（スプレー薬、服用薬、その他）、用途別セグメント分析（動物病院、動物病院、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Boehringer Ingelheim、Wellmark International, Inc、HEARTGARD Plus、Merck Animal Health (Merck & Co., Inc.)、Pfizer Inc、Bayer AG、Mylan N.V、Ceva Sante Animale S.A、PetCareRx、Ecto Development Corporationなどが含まれています。フィラリア症治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、フィラリア症治療市場規模を算出する際に考慮しました。

・フィラリア症治療市場の概要
- フィラリア症治療の種類別セグメント
- 世界のフィラリア症治療市場規模：タイプ別分析（スプレー薬、服用薬、その他）
- フィラリア症治療の用途別セグメント
- 世界のフィラリア症治療市場規模：用途別分析（動物病院、動物病院、その他）
- 世界のフィラリア症治療市場規模予測（2018年-2029年）

・フィラリア症治療市場の成長トレンド
- フィラリア症治療の地域別市場規模（2018年-2029年）
- フィラリア症治療市場ダイナミクス
- フィラリア症治療の業界動向
- フィラリア症治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：スプレー薬、服用薬、その他
- 世界のフィラリア症治療のタイプ別市場規模（2018年-2023年）
- 世界のフィラリア症治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：動物病院、動物病院、その他
- 世界のフィラリア症治療の用途別市場規模（2018年-2023年）
- 世界のフィラリア症治療の用途別市場規模（2024年-2029年）

・フィラリア症治療の地域別市場規模
- 北米のフィラリア症治療市場規模（2018年-2029年）
- 米国のフィラリア症治療市場規模（2018年-2029年）
- ヨーロッパのフィラリア症治療市場規模（2018年-2029年）
- アジア太平洋のフィラリア症治療市場規模（2018年-2029年）
- 中国のフィラリア症治療市場規模（2018年-2029年）
- 日本のフィラリア症治療市場規模（2018年-2029年）
- 韓国のフィラリア症治療市場規模（2018年-2029年）
- インドのフィラリア症治療市場規模（2018年-2029年）
- オーストラリアのフィラリア症治療市場規模（2018年-2029年）
- 中南米のフィラリア症治療市場規模（2018年-2029年）
- 中東・アフリカのフィラリア症治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Boehringer Ingelheim、Wellmark International, Inc、HEARTGARD Plus、Merck Animal Health (Merck & Co., Inc.)、Pfizer Inc、Bayer AG、Mylan N.V、Ceva Sante Animale S.A、PetCareRx、Ecto Development Corporation

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Heartworm Disease Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Heartworm Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Heartworm Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Heartworm Disease Treatment in Animal Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Heartworm Disease Treatment include Boehringer Ingelheim, Wellmark International, Inc, HEARTGARD Plus, Merck Animal Health (Merck & Co., Inc.), Pfizer Inc, Bayer AG, Mylan N.V, Ceva Sante Animale S.A and PetCareRx, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heartworm Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heartworm Disease Treatment.
The Heartworm Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Heartworm Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heartworm Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Boehringer Ingelheim
Wellmark International, Inc
HEARTGARD Plus
Merck Animal Health (Merck & Co., Inc.)
Pfizer Inc
Bayer AG
Mylan N.V
Ceva Sante Animale S.A
PetCareRx
Ecto Development Corporation
Segment by Type
Spray Medicine
Take Medicine
Others
Segment by Application
Animal Hospital
Veterinary Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Heartworm Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heartworm Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Spray Medicine
1.2.3 Take Medicine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Heartworm Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Animal Hospital
1.3.3 Veterinary Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Heartworm Disease Treatment Market Perspective (2018-2029)
2.2 Heartworm Disease Treatment Growth Trends by Region
2.2.1 Global Heartworm Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Heartworm Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Heartworm Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Heartworm Disease Treatment Market Dynamics
2.3.1 Heartworm Disease Treatment Industry Trends
2.3.2 Heartworm Disease Treatment Market Drivers
2.3.3 Heartworm Disease Treatment Market Challenges
2.3.4 Heartworm Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Heartworm Disease Treatment Players by Revenue
3.1.1 Global Top Heartworm Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Heartworm Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Heartworm Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Heartworm Disease Treatment Revenue
3.4 Global Heartworm Disease Treatment Market Concentration Ratio
3.4.1 Global Heartworm Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Heartworm Disease Treatment Revenue in 2022
3.5 Heartworm Disease Treatment Key Players Head office and Area Served
3.6 Key Players Heartworm Disease Treatment Product Solution and Service
3.7 Date of Enter into Heartworm Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Heartworm Disease Treatment Breakdown Data by Type
4.1 Global Heartworm Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Heartworm Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Heartworm Disease Treatment Breakdown Data by Application
5.1 Global Heartworm Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Heartworm Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Heartworm Disease Treatment Market Size (2018-2029)
6.2 North America Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Heartworm Disease Treatment Market Size by Country (2018-2023)
6.4 North America Heartworm Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Heartworm Disease Treatment Market Size (2018-2029)
7.2 Europe Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Heartworm Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Heartworm Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Heartworm Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Heartworm Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Heartworm Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Heartworm Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Heartworm Disease Treatment Market Size (2018-2029)
9.2 Latin America Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Heartworm Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Heartworm Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Heartworm Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Heartworm Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Heartworm Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Heartworm Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Heartworm Disease Treatment Introduction
11.1.4 Boehringer Ingelheim Revenue in Heartworm Disease Treatment Business (2018-2023)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Wellmark International, Inc
11.2.1 Wellmark International, Inc Company Detail
11.2.2 Wellmark International, Inc Business Overview
11.2.3 Wellmark International, Inc Heartworm Disease Treatment Introduction
11.2.4 Wellmark International, Inc Revenue in Heartworm Disease Treatment Business (2018-2023)
11.2.5 Wellmark International, Inc Recent Development
11.3 HEARTGARD Plus
11.3.1 HEARTGARD Plus Company Detail
11.3.2 HEARTGARD Plus Business Overview
11.3.3 HEARTGARD Plus Heartworm Disease Treatment Introduction
11.3.4 HEARTGARD Plus Revenue in Heartworm Disease Treatment Business (2018-2023)
11.3.5 HEARTGARD Plus Recent Development
11.4 Merck Animal Health (Merck & Co., Inc.)
11.4.1 Merck Animal Health (Merck & Co., Inc.) Company Detail
11.4.2 Merck Animal Health (Merck & Co., Inc.) Business Overview
11.4.3 Merck Animal Health (Merck & Co., Inc.) Heartworm Disease Treatment Introduction
11.4.4 Merck Animal Health (Merck & Co., Inc.) Revenue in Heartworm Disease Treatment Business (2018-2023)
11.4.5 Merck Animal Health (Merck & Co., Inc.) Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Detail
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Heartworm Disease Treatment Introduction
11.5.4 Pfizer Inc Revenue in Heartworm Disease Treatment Business (2018-2023)
11.5.5 Pfizer Inc Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Detail
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Heartworm Disease Treatment Introduction
11.6.4 Bayer AG Revenue in Heartworm Disease Treatment Business (2018-2023)
11.6.5 Bayer AG Recent Development
11.7 Mylan N.V
11.7.1 Mylan N.V Company Detail
11.7.2 Mylan N.V Business Overview
11.7.3 Mylan N.V Heartworm Disease Treatment Introduction
11.7.4 Mylan N.V Revenue in Heartworm Disease Treatment Business (2018-2023)
11.7.5 Mylan N.V Recent Development
11.8 Ceva Sante Animale S.A
11.8.1 Ceva Sante Animale S.A Company Detail
11.8.2 Ceva Sante Animale S.A Business Overview
11.8.3 Ceva Sante Animale S.A Heartworm Disease Treatment Introduction
11.8.4 Ceva Sante Animale S.A Revenue in Heartworm Disease Treatment Business (2018-2023)
11.8.5 Ceva Sante Animale S.A Recent Development
11.9 PetCareRx
11.9.1 PetCareRx Company Detail
11.9.2 PetCareRx Business Overview
11.9.3 PetCareRx Heartworm Disease Treatment Introduction
11.9.4 PetCareRx Revenue in Heartworm Disease Treatment Business (2018-2023)
11.9.5 PetCareRx Recent Development
11.10 Ecto Development Corporation
11.10.1 Ecto Development Corporation Company Detail
11.10.2 Ecto Development Corporation Business Overview
11.10.3 Ecto Development Corporation Heartworm Disease Treatment Introduction
11.10.4 Ecto Development Corporation Revenue in Heartworm Disease Treatment Business (2018-2023)
11.10.5 Ecto Development Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Heartworm Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Spray Medicine
Table 3. Key Players of Take Medicine
Table 4. Key Players of Others
Table 5. Global Heartworm Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Heartworm Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Heartworm Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Heartworm Disease Treatment Market Share by Region (2018-2023)
Table 9. Global Heartworm Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Heartworm Disease Treatment Market Share by Region (2024-2029)
Table 11. Heartworm Disease Treatment Market Trends
Table 12. Heartworm Disease Treatment Market Drivers
Table 13. Heartworm Disease Treatment Market Challenges
Table 14. Heartworm Disease Treatment Market Restraints
Table 15. Global Heartworm Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Heartworm Disease Treatment Market Share by Players (2018-2023)
Table 17. Global Top Heartworm Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heartworm Disease Treatment as of 2022)
Table 18. Ranking of Global Top Heartworm Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Heartworm Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Heartworm Disease Treatment Product Solution and Service
Table 22. Date of Enter into Heartworm Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Heartworm Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Heartworm Disease Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Heartworm Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Heartworm Disease Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Heartworm Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Heartworm Disease Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Heartworm Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Heartworm Disease Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Heartworm Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Heartworm Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Heartworm Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Heartworm Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Heartworm Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Heartworm Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Heartworm Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Heartworm Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Heartworm Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Heartworm Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Heartworm Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Heartworm Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Heartworm Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Heartworm Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Heartworm Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Boehringer Ingelheim Company Detail
Table 48. Boehringer Ingelheim Business Overview
Table 49. Boehringer Ingelheim Heartworm Disease Treatment Product
Table 50. Boehringer Ingelheim Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 51. Boehringer Ingelheim Recent Development
Table 52. Wellmark International, Inc Company Detail
Table 53. Wellmark International, Inc Business Overview
Table 54. Wellmark International, Inc Heartworm Disease Treatment Product
Table 55. Wellmark International, Inc Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 56. Wellmark International, Inc Recent Development
Table 57. HEARTGARD Plus Company Detail
Table 58. HEARTGARD Plus Business Overview
Table 59. HEARTGARD Plus Heartworm Disease Treatment Product
Table 60. HEARTGARD Plus Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 61. HEARTGARD Plus Recent Development
Table 62. Merck Animal Health (Merck & Co., Inc.) Company Detail
Table 63. Merck Animal Health (Merck & Co., Inc.) Business Overview
Table 64. Merck Animal Health (Merck & Co., Inc.) Heartworm Disease Treatment Product
Table 65. Merck Animal Health (Merck & Co., Inc.) Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 66. Merck Animal Health (Merck & Co., Inc.) Recent Development
Table 67. Pfizer Inc Company Detail
Table 68. Pfizer Inc Business Overview
Table 69. Pfizer Inc Heartworm Disease Treatment Product
Table 70. Pfizer Inc Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 71. Pfizer Inc Recent Development
Table 72. Bayer AG Company Detail
Table 73. Bayer AG Business Overview
Table 74. Bayer AG Heartworm Disease Treatment Product
Table 75. Bayer AG Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 76. Bayer AG Recent Development
Table 77. Mylan N.V Company Detail
Table 78. Mylan N.V Business Overview
Table 79. Mylan N.V Heartworm Disease Treatment Product
Table 80. Mylan N.V Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 81. Mylan N.V Recent Development
Table 82. Ceva Sante Animale S.A Company Detail
Table 83. Ceva Sante Animale S.A Business Overview
Table 84. Ceva Sante Animale S.A Heartworm Disease Treatment Product
Table 85. Ceva Sante Animale S.A Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 86. Ceva Sante Animale S.A Recent Development
Table 87. PetCareRx Company Detail
Table 88. PetCareRx Business Overview
Table 89. PetCareRx Heartworm Disease Treatment Product
Table 90. PetCareRx Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 91. PetCareRx Recent Development
Table 92. Ecto Development Corporation Company Detail
Table 93. Ecto Development Corporation Business Overview
Table 94. Ecto Development Corporation Heartworm Disease Treatment Product
Table 95. Ecto Development Corporation Revenue in Heartworm Disease Treatment Business (2018-2023) & (US$ Million)
Table 96. Ecto Development Corporation Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Heartworm Disease Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Heartworm Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Spray Medicine Features
Figure 4. Take Medicine Features
Figure 5. Others Features
Figure 6. Global Heartworm Disease Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Heartworm Disease Treatment Market Share by Application: 2022 VS 2029
Figure 8. Animal Hospital Case Studies
Figure 9. Veterinary Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Heartworm Disease Treatment Report Years Considered
Figure 12. Global Heartworm Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Heartworm Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Heartworm Disease Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Heartworm Disease Treatment Market Share by Players in 2022
Figure 16. Global Top Heartworm Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heartworm Disease Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Heartworm Disease Treatment Revenue in 2022
Figure 18. North America Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Heartworm Disease Treatment Market Share by Country (2018-2029)
Figure 20. United States Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Heartworm Disease Treatment Market Share by Country (2018-2029)
Figure 24. Germany Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Heartworm Disease Treatment Market Share by Region (2018-2029)
Figure 32. China Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Heartworm Disease Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Heartworm Disease Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Heartworm Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 47. Wellmark International, Inc Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 48. HEARTGARD Plus Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 49. Merck Animal Health (Merck & Co., Inc.) Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 50. Pfizer Inc Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 51. Bayer AG Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 52. Mylan N.V Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 53. Ceva Sante Animale S.A Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 54. PetCareRx Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 55. Ecto Development Corporation Revenue Growth Rate in Heartworm Disease Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のフィラリア治療製品市場2022年：市場規模予測（～2028年）
  • ブルセラ症治療の世界市場2023年：経口式、注射式
  • 関節内出血治療の世界市場2023年：手術治療、医療治療
  • 膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他
  • 四肢麻痺治療の世界市場2023年：経口、点滴、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8782 )"フィラリア症治療の世界市場2023年：スプレー薬、服用薬、その他" (英文：Global Heartworm Disease Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。